Epstein-Barr virus episome-based promoter function in human myeloid cells

Area of Science:

• Molecular Biology
• Gene Expression
• Virology

Background:

• Epstein-Barr virus (EBV) episomal replicons facilitate gene amplification in human cells.
• EBV episomes are valuable tools for stable gene expression studies.

Purpose of the Study:

• To evaluate the efficacy of different eukaryotic promoter elements for gene expression using EBV episomes.
• To identify optimal promoters for high-level and inducible gene expression in human myeloid leukemia cells.

Main Methods:

• Construction and transfection of a panel of EBV episomes containing various promoter elements into human myeloid leukemia cells.
• Assessment of gene expression levels and inducibility mediated by different promoters.
• Analysis of episome copy numbers to differentiate promoter activity from episome stability.

Main Results:

• The Rous sarcoma virus 3' LTR demonstrated the highest suitability for EBV episome-based gene expression.
• Lymphopapilloma virus and SV40 early regulatory elements showed significantly lower activities.
• Chemically responsive promoters (SV40 early, human metallothionein IIA, rat GRP78) maintained inducibility on EBV episomes.
• Observed differences in gene expression were attributed to promoter activity, not variations in episome copy number.

Conclusions:

• The Rous sarcoma virus 3' LTR is the preferred promoter for robust EBV episome-mediated gene expression.
• EBV episomal expression vectors can be designed with specific promoters to achieve desired expression levels and inducibility.
• These findings offer essential guidelines for constructing efficient EBV episomal expression vectors for human cell applications.